SAN DIEGO–(BUSINESS WIRE)–Entos, Inc. (“Entos” or “the Company”), the creator of a cutting-edge platform combining AI-driven technology and automated synthesis to design small-molecule therapeutics, today announced that it has appointed Jack Taunton, Professor of Cellular Molecular Pharmacology at University of California, San Francisco, and Ken Brameld, Senior Advisor for Samsara Biocapital, to the Company’s Scientific Advisory Board. “The addition of Jack and Ken to our team brings further